Skip to main content
Year archive

Xvivo Perfusion — 2021 filings

All 30 regulatory filings released by Xvivo Perfusion (XVIVO) in 2021, sourced directly from the official regulator.

30 Filings
2021 Period
2021 filings (30)
Filing Released Lang
Major Shareholding Notification 2021
Major Shareholding Notification
2021-12-27 English
Increased number of shares and votes in XVIVO Perfusion AB (publ)
Declaration of Voting Results & Voting Rights Announcements
2021-11-30 English
Ökat antal aktier och röster i XVIVO Perfusion AB (publ)
Declaration of Voting Results & Voting Rights Announcements
2021-11-30 Swedish
Director's Dealing 2021
Director's Dealing
2021-11-01 English
Major Shareholding Notification 2021
Major Shareholding Notification
2021-11-01 Swedish
XVIVO Perfusion has carried out a directed share issue of 746,269 shares at a subscription price of SEK 335 per share
Share Issue/Capital Change
2021-10-28 English
XVIVO Perfusion har genomfört en riktad nyemission av 746 269 aktier till en teckningskurs om 335 kronor per aktie
Share Issue/Capital Change
2021-10-28 Swedish
XVIVO Perfusion intends to carry out a directed issue of shares
Share Issue/Capital Change
2021-10-28 English
XVIVO Perfusion avser att genomföra en riktad nyemission av aktier
Capital/Financing Update
2021-10-28 Swedish
XVIVO has entered into an agreement to acquire the US organ recovery company Star Teams and finances the acquisition through a private placement of new shares
M&A Activity
2021-10-28 English
XVIVO har ingått avtal om att förvärva det amerikanska företaget för organhämtning, Star Teams, och finansierar förvärvet genom en nyemission av aktier
M&A Activity
2021-10-28 Swedish
Interim / Quarterly Report 2021
Interim / Quarterly Report 9M 2021
2021-10-21 Swedish
Interim / Quarterly Report 2021
Interim / Quarterly Report 9M 2021
2021-10-21 English
Language correction: XVIVO Capital Markets Day presents strategic focus areas for 2022-2026
Report Publication Announcement
2021-09-23 English
XVIVO presenterar strategiska fokusområden för 2022-2026 på kapitalmarknadsdagen
Regulatory Filings
2021-09-23 Swedish
XVIVO Capital Markets Day presents strategic focus areas for 2022-2026
Investor Presentation
2021-09-23 Swedish
Interim / Quarterly Report 2021
Interim / Quarterly Report H1 2021
2021-07-13 Swedish
Interim / Quarterly Report 2021
Interim / Quarterly Report H1 2021
2021-07-13 English
Change in number of shares and votes in XVIVO Perfusion
Declaration of Voting Results & Voting Rights Announcements
2021-06-30 English
Förändring av antalet aktier och röster i XVIVO Perfusion
Share Issue/Capital Change
2021-06-30 Swedish
Kommuniké från årsstämma i XVIVO Perfusion AB (publ)
AGM Information
2021-04-22 Swedish
Bulletin from Annual General Meeting in XVIVO Perfusion AB (publ)
AGM Information
2021-04-22 English
Interim / Quarterly Report 2021
Interim / Quarterly Report Q1 2021
2021-04-21 Swedish
Interim / Quarterly Report 2021
Interim / Quarterly Report Q1 2021
2021-04-21 English
Annual Report (ESEF) 2020
Annual Report (ESEF) FY 2020
2021-03-29 Swedish
Annual Report (ESEF) 2020
Annual Report (ESEF) FY 2020
2021-03-29 English
Notice to attend the Annual General Meeting in XVIVO Perfusion AB (publ)
AGM Information
2021-03-15 English
Kallelse till årsstämma i XVIVO Perfusion AB (publ)
AGM Information
2021-03-15 Swedish
Earnings Release 2020
Earnings Release Q4 2020
2021-01-28 Swedish
Interim / Quarterly Report 2020
Interim / Quarterly Report FY 2020
2021-01-28 English